scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1045801502 |
P356 | DOI | 10.1038/MODPATHOL.3880076 |
P698 | PubMed publication ID | 10786813 |
P2093 | author name string | Sigel JE | |
Hsi ED | |||
P2860 | cites work | Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype | Q70496921 |
Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas | Q70789099 | ||
Fas ligand and immune evasion | Q71840940 | ||
Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients | Q72953743 | ||
Distinctive clinicopathologic features associated with regressive primary CD30 positive cutaneous lymphomas: analysis of 6 cases | Q73186852 | ||
Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases | Q73543128 | ||
Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression | Q73981632 | ||
Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family | Q28285445 | ||
The Fas death factor | Q29620461 | ||
Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity | Q33488225 | ||
Fas and Fas ligand: lpr and gld mutations | Q40398275 | ||
Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment | Q40854148 | ||
Fas and FasL in the homeostatic regulation of immune responses | Q40957267 | ||
Downregulation of Fas ligand by shedding | Q41071790 | ||
Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines | Q42651249 | ||
A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki-1)-positive anaplastic large cell lymphoma. | Q53462456 | ||
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Grou | Q57786781 | ||
Cutaneous CD30+ lymphoproliferative disorders: Expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily | Q58482188 | ||
Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases | Q68456240 | ||
A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma | Q70470137 | ||
P433 | issue | 4 | |
P921 | main subject | immunohistochemistry | Q899285 |
lymphoproliferative disorders | Q4165484 | ||
P304 | page(s) | 446-451 | |
P577 | publication date | 2000-04-01 | |
P1433 | published in | Modern Pathology | Q15724578 |
P1476 | title | Immunohistochemical analysis of CD30-positive lymphoproliferative disorders for expression of CD95 and CD95L | |
P478 | volume | 13 |
Search more.